Vatalanib and Pemetrexed Disodium in Treating Patients With Advanced Solid Tumors
Status:
Completed
Trial end date:
2016-08-04
Target enrollment:
Participant gender:
Summary
RATIONALE: Vatalanib and pemetrexed disodium may stop the growth of tumor cells by blocking
some of the enzymes needed for cell growth. Vatalanib may also stop the growth of tumor cells
by blocking blood flow to the tumor. Giving vatalanib together with pemetrexed disodium may
kill more tumor cells.
PURPOSE: This phase I trial is studying the side effects and best dose of vatalanib when
given together with pemetrexed disodium in treating patients with advanced solid tumors.